Leaps by Bayer
Corporate VC
Leaps is the strategic impact investment unit of Bayer, founded in 2015. Has invested over $1 billion in ventures pursuing scientific breakthroughs in health (curing/preventing diseases) and agriculture (sustainable food production).
Early Stage
Growth
Seed
Late Stage
Agtech
Biotech
Drug Development
Life Sciences
Healthcare
Deep Tech
Medtech
- Headquarters
- Leverkusen, Germany
- Founded
- 2015
- Website
- leaps.bayer.com
- AUM
- $2.1B
- Total Investments
- 26
- Last Investment
- Dec 2024
- Geographic Focus
- Global, United States, Europe, Germany, Worldwide
Investment Thesis
Invests via minority equity stakes in teams pursuing fundamental breakthroughs targeting 10 huge challenges in health and agriculture, aiming to shift paradigms with transformative therapies and technologies.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account